{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:06:46Z","timestamp":1753888006221,"version":"3.41.2"},"reference-count":38,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Braz J Med Biol Res"],"DOI":"10.1590\/1414-431x2022e12324","type":"journal-article","created":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T13:36:40Z","timestamp":1662989800000},"source":"Crossref","is-referenced-by-count":1,"title":["The antitumor activity of hPRDX5 against pancreatic cancer and the possible mechanisms"],"prefix":"10.1590","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7921-4225","authenticated-orcid":false,"given":"Lihua","family":"Cui","sequence":"first","affiliation":[{"name":"Tianjin Nankai Hospital,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1284-9736","authenticated-orcid":false,"given":"Yuanyuan","family":"Jin","sequence":"additional","affiliation":[{"name":"Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences, No. 1 Tiantanxili,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6593-0618","authenticated-orcid":false,"given":"Sen","family":"Zou","sequence":"additional","affiliation":[{"name":"Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences, No. 1 Tiantanxili,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8730-4212","authenticated-orcid":false,"given":"Jing","family":"Xun","sequence":"additional","affiliation":[{"name":"Tianjin Nankai Hospital,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3688-347X","authenticated-orcid":false,"given":"Xiangyang","family":"Yu","sequence":"additional","affiliation":[{"name":"Tianjin University,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7817-2211","authenticated-orcid":false,"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Tianjin Nankai Hospital,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7197-3991","authenticated-orcid":false,"given":"Zhaoyong","family":"Yang","sequence":"additional","affiliation":[{"name":"Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences, No. 1 Tiantanxili,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2022]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib L","year":"2014","journal-title":"Cancer Res"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel R","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0002-9440(10)65149-8","article-title":"Tumor-associated transforming growth factor-beta and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patients","volume":"155","author":"Bellone G","year":"1999","journal-title":"Am J Pathol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ni1261","article-title":"A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17","volume":"6","author":"Park H","year":"2005","journal-title":"Nat Immunol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.4049\/jimmunol.0902609","article-title":"Induction of Th17 cells in the tumor microenvironment improves survival in a murine model of pancreatic cancer","volume":"185","author":"Gnerlich JL","year":"2010","journal-title":"J Immunol"},{"key":"ref6","first-page":"337","article-title":"Enhancement of anti-tumor immunity by high levels of Th1 and Th17 with a combination of dendritic cell fusion hybrids and regulatory T cell depletion in pancreatic cancer","volume":"22","author":"Yamamoto M","year":"2009","journal-title":"Oncol Rep"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2310\/JIM.0b013e31824a4d79","article-title":"Pancreatic ductal adenocarcinoma: a review of immunologic aspects","volume":"60","author":"Wachsmann MB","year":"2012","journal-title":"J Investig Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/01.mpa.0000240275.68279.13","article-title":"Clinical roles of increased populations of Foxp3+CD4+ T cells in peripheral blood from advanced pancreatic cancer patients","volume":"33","author":"Ikemoto T","year":"2006","journal-title":"Pancreas"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1365-2249.1993.tb08198.x","article-title":"Functional analysis of TCR gamma delta+ T cells in tumour-infiltrating lymphocytes (TIL) of human pancreatic cancer","volume":"93","author":"Kitayama J","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00423-008-0393-4","article-title":"Interleukin-2 immunotherapy action on innate immunity cells in peripheral blood and tumoral tissue of pancreatic adenocarcinoma patients","volume":"394","author":"Degrate L","year":"2009","journal-title":"Langenbecks Arch Surg"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/bjc.1984.168","article-title":"Decreased natural killer cell activity and interferon production by leucocytes in patients with adenocarcinoma of the pancreas","volume":"50","author":"Funa K","year":"1984","journal-title":"Br J Cancer"},{"key":"ref12","first-page":"27","article-title":"Natural killer cell activity in patients with adenocarcinoma in the upper gastrointestinal tract","volume":"35","author":"Aparicio-Pag\u00e9s MN","year":"1991","journal-title":"J Clin Lab Immunol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich DI","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"5791","DOI":"10.4049\/jimmunol.181.8.5791","article-title":"Subsets of myeloid-derived suppressor cells in tumor-bearing mice","volume":"181","author":"Youn JI","year":"2008","journal-title":"J Immunol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.it.2010.10.002","article-title":"Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function","volume":"32","author":"Condamine T","year":"2011","journal-title":"Trends Immunol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1182\/blood-2007-07-099226","article-title":"Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity","volume":"111","author":"Movahedi K","year":"2008","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"24467","DOI":"10.1038\/srep24467","article-title":"The identification of goat peroxiredoxin-5 and the evaluation and enhancement of its stability by nanoparticle formation","volume":"6","author":"Feng X","year":"2016","journal-title":"Sci Rep"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"44822","DOI":"10.1038\/srep44822","article-title":"Astragalus polysaccharides exerts immunomodulatory effects via TLR4-mediated MyD88-dependent signaling pathway in vitro and in vivo","volume":"7","author":"Zhou L","year":"2017","journal-title":"Sci Rep"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1038\/s41598-017-01868-0","article-title":"Identification and activation of TLR4-mediated signalling pathways by alginate-derived guluronate oligosaccharide in RAW264.7 macrophages","volume":"7","author":"Fang W","year":"2017","journal-title":"Sci Rep"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"5508","DOI":"10.1172\/JCI137585","article-title":"Thioredoxin activity confers resistance against oxidative stress in tumor-infiltrating NK cells","volume":"130","author":"Yang Y","year":"2020","journal-title":"J Clin Invest"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1038\/onc.2013.257","article-title":"The immune network in pancreatic cancer development and progression","volume":"33","author":"W\u00f6rmann SM","year":"2014","journal-title":"Oncogene"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nrclinonc.2015.53","article-title":"Pancreatic cancer: from state-of-the-art treatments to promising novel therapies","volume":"12","author":"Garrido-Laguna I","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s00262-003-0443-2","article-title":"Derangement of immune responses by myeloid suppressor cells","volume":"53","author":"Serafini P","year":"2004","journal-title":"Cancer Immunol Immunother"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1172\/JCI28828","article-title":"Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells","volume":"116","author":"Gallina G","year":"2006","journal-title":"J Clin Invest"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1172\/JCI29906","article-title":"Myeloid suppressor cells regulate the adaptive immune response to cancer","volume":"116","author":"Frey AB","year":"2006","journal-title":"J Clin Invest"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/00002371-200111000-00001","article-title":"Tumor-induced immune dysfunctions caused by myeloid suppressor cells","volume":"24","author":"Bronte V","year":"2001","journal-title":"J Immunother"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"6713","DOI":"10.1158\/1078-0432.CCR-05-0883","article-title":"Gemcitabine selectively eliminates splenic Gr-1+\/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity","volume":"11","author":"Suzuki E","year":"2005","journal-title":"Clin Cancer Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/bjc.2013.32","article-title":"Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer","volume":"108","author":"Ino Y","year":"2013","journal-title":"Br J Cancer"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1097\/00006676-200401000-00023","article-title":"CD8+ tumor-infiltrating lymphocytes together with CD4+ tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma","volume":"28","author":"Fukunaga A","year":"2004","journal-title":"Pancreas"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ctrv.2013.11.005","article-title":"Role of the immune system in pancreatic cancer progression and immune modulating treatment strategies","volume":"40","author":"Sideras K","year":"2014","journal-title":"Cancer Treat Rev"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/nrc928","article-title":"New aspects of natural-killer-cell surveillance and therapy of cancer","volume":"2","author":"Smyth MJ","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/cei.12392","article-title":"Lung cancer is associated with decreased expression of perforin, granzyme B and interferon (IFN)-gamma by infiltrating lung tissue T cells, natural killer (NK) T-like and NK cells","volume":"178","author":"Hodge G","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"949","DOI":"10.2217\/imt.09.70","article-title":"Toll-like receptor agonists in cancer therapy","volume":"1","author":"Adams S","year":"2009","journal-title":"Immunotherapy"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.biocel.2009.10.009","article-title":"The role of toll-like receptors in chronic inflammation","volume":"42","author":"Drexler SK","year":"2010","journal-title":"Int J Biochem Cell Biol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"5206","DOI":"10.1016\/j.biomaterials.2011.03.052","article-title":"The induction of innate and adaptive immunity by biodegradable poly(gamma-glutamic acid) nanoparticles via a TLR4 and MyD88 signaling pathway","volume":"32","author":"Uto T","year":"2011","journal-title":"Biomaterials"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrc2628","article-title":"Tumour necrosis factor and cancer","volume":"9","author":"Balkwill F","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"609579","DOI":"10.1155\/2011\/609579","article-title":"Toll-like receptor 4 activation in cancer progression and therapy","volume":"2011","author":"Oblak A","year":"2011","journal-title":"Clin Dev Immunol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"271246","DOI":"10.1155\/2013\/271246","article-title":"Combinations of TLR ligands: a promising approach in cancer immunotherapy","volume":"2013","author":"Stier S","year":"2013","journal-title":"Clin Dev Immunol"}],"container-title":["Brazilian Journal of Medical and Biological Research"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0100-879X2022000100658&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T13:37:15Z","timestamp":1662989835000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0100-879X2022000100658&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":38,"alternative-id":["S0100-879X2022000100658"],"URL":"https:\/\/doi.org\/10.1590\/1414-431x2022e12324","relation":{},"ISSN":["1414-431X","0100-879X"],"issn-type":[{"type":"electronic","value":"1414-431X"},{"type":"print","value":"0100-879X"}],"subject":[],"published":{"date-parts":[[2022]]},"article-number":"e12324"}}